Hence, we concluded a novel molecular mechanism in which ERO1α promoted the metastasis and angiogenesis of HCC through S1PR1/STAT3/VEGF-A signaling, suggesting that reagents targeting the pathway would be beneficial for inhibiting tumor metastasis and angiogenesis. The gene discussed is ERO1A; the disease is hepatocellular carcinoma.